Montreal General Hospital - Alan Edwards Pain Management Unit
Montreal, Quebec, H3G 1A4, Canada
NCT Number: NCT01352013
The purpose of this study is to find out if omega-3 fatty acid supplements are more effective than an inactive placebo at reducing pain, reducing fatigue and elevating mood in patients with fibromyalgia.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Phase 2
Montreal, Quebec, H3G 1A4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5ml daily with breakfast for 56 days.
Other names: NutraSea HP
5ml daily with breakfast for 56 days.
Time frame: 2 months
Pain intensity
Time frame: 2 months
Time frame: 2 months
Changes in levels of patients' pain unpleasantness, fatigue, sleep quality, mood and mental confusion.
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months
Dr. Yoram Shir
Other
The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia (FM) Symptoms: A Randomized, Double-blind, Placebo-controlled Exploratory Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04729179
Chronic Pain, Fatigue
Copenhagen, Denmark
View Trial DetailsNCT02872129
Chronic Pain, Chronic Widespread Pain
Alingsås, Sweden
View Trial DetailsNCT01107574
Chronic Pain, Dyssomnias
Vallejo, California, United States
View Trial DetailsNCT00524420
Behavior, Behavioral Symptoms
Seattle, Washington, United States
View Trial Details